Integrated Omic Analysis Delineates Pathways Modulating Toxic TDP-43 Protein Aggregates in Amyotrophic Lateral Sclerosis

Abstract

Amyotrophic lateral sclerosis (ALS) is a multi-systemic, incurable, amyloid disease affecting the motor neurons, resulting in the death of patients. The disease is either sporadic or familial with SOD1, C9orf72, FUS, and TDP-43 constituting the majority of familial ALS. Multi-omics studies on patients and model systems like mice and yeast have helped in understanding the association of various signaling and metabolic pathways with the disease. The yeast model system has played a pivotal role in elucidating the gene amyloid interactions. We carried out an integrated transcriptomic and metabolomic analysis of the TDP-43 expressing yeast model to elucidate deregulated pathways associated with the disease. The analysis shows the deregulation of the TCA cycle, single carbon metabolism, glutathione metabolism, and fatty acid metabolism. Transcriptomic analysis of GEO datasets of TDP-43 expressing motor neurons from mice models of ALS and ALS patients shows considerable overlap with experimental results. Furthermore, a yeast model was used to validate the obtained results using metabolite addition and gene knock-out experiments. Taken together, our result shows a potential role for the TCA cycle, cellular redox pathway, NAD metabolism, and fatty acid metabolism in disease. Supplementation of reduced glutathione, nicotinate, and the keto diet might help to manage the disease.

Genetic associations with dementia‐related proteinopathy: Application of item response theory

“… 65 , 66 Recent studies showed that the deregulated metabolism of glycerolipid was associated with ALS risk. 67 , 68 Given that the A allele of rs28610182 had a protective effect (shown in Supplementary Table 6 ) and was associated with upregulated TMEM68 expression in human brain (shown in Supplementary Table 12 ), our findings may indicate a protective influence of this protein product and/or the glycerolipid metabolism pathway, in LATE‐NC.…”

Saccharomyces cerevisiae as a Model for Studying Human Neurodegenerative Disorders: Viral Capsid Protein Expression

“…Integrated transcriptomic and metabolomic analysis is the most recently developed and promising methodological approach that uses yeast as a model system to understand the biological role of the described proteins in the deregulation of pathways associated with the disease. To date, only preliminary, but encouraging, results have been obtained, and in our view, further research is warranted [139,140].…”

Synthesis, computational docking and molecular dynamics studies of a new class of spiroquinoxalinopyrrolidine embedded chromanone hybrids as potent anti-cholinesterase agents

“…Alzheimer's disease (AD), Parkinson's disease, and Huntington's disease (HD) are among the neurodegenerative diseases associated with protein aggregation and lead to cognitive, behavioral, and motor dysfunction. 1–5 A study conducted by the WHO estimated that over thirty seven million individuals around the world are terribly affected by AD 6 and that the number will reach 66 million by 2030 and 115 million by 2050. 7 The disease is clinically identified by amnestic cognitive impairment, learning disability, memory loss, and a wide array of neuropsychiatric signs during midlife and late life, which indicate that this disease affects the ability to think and perform daily activities independently.…”